1-5 of 5
Melissa Kives
Close
Sort by
Journal Articles

Overall Survival Following First and Second Relapse of DLBCL Treated with Therapies Including Autologous Transplant and CAR-T Cells: Results from the Lion Prospective Observational Registry

Greg Kirkpatrick, Jeffrey M. Switchenko, Melissa Kives, Katelin Baird, Kami J. Maddocks, Jason T. Romancik, Deborah M. Stephens, Harsh Shah, Javier Pinilla-Ibarz, Julio C Chavez, Matthew Matasar, Craig A. Portell, Michelle Churchman, Jonathon B. Cohen, Umar Farooq, Brian K. Link
Journal: Blood
Blood (2023) 142 (Supplement 1): 6325.
https://doi.org/10.1182/blood-2023-187198
Published: 2023
Journal Articles

Engaging Underrepresented Patients in Hematology Clinical Trials through the LLS Impact (Influential Medicine Providing Access to Clinical Trials) Research Grant: A Multi-Institutional Effort

Eden Ayele Biltibo, Zachary Copeland, Erik Nelson, Nina Logan, Kellie Jack, Jamie Johnston, Veronica Leautaud, Lammers Philip, Salil Goorha, Brion Randolph, Jonathon B. Cohen, Melissa Kives, Michael Yaffe, Lee M. Greenberger, Christopher R. Flowers, Tanya Siddiqi, Clayton Smith, Erica Phillips, John P. Leonard, Grzegorz S. Nowakowski, Michael R. Savona
Journal: Blood
Blood (2023) 142 (Supplement 1): 7237.
https://doi.org/10.1182/blood-2023-191067
Published: 2023
Journal Articles

Weight Change Trends and Impact of Body Mass Index (BMI) on Outcomes in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma, a Retrospective Analysis from the Lymphoma Innovations Orien Network (LION) Consortium

Yazeed Sawalha, Chenxi Du, Jeffrey M. Switchenko, Melissa Kives, Michelle L. Churchman, Deborah M. Stephens, Javier Pinilla Ibarz, Andrew Matthew Evens, Kami J. Maddocks, Brian K. Link, Jonathon B. Cohen, Craig A. Portell
Journal: Blood
Blood (2022) 140 (Supplement 1): 11956–11958.
https://doi.org/10.1182/blood-2022-163681
Published: 2022
Journal Articles

A Large Multicenter Real-World Evidence (RWE) Analysis of Autoimmune (AI) Diseases and Lymphoma: Histologic Associations, Disease Characteristics, Survival, and Prognostication

Jordan Carter, Adam J. Olszewski, Tatyana A. Feldman, Reem Karmali, Jean L. Koff, Sabarish Ayyappan, Matthew A. Lunning, Shazia Nakohda, Nadia Khan, Aryeh Pelcovits, Jason Lofters, Timothy Seijung Oh, Colin Burke O'Leary, Kittika Poonsombudlert, Carman Tong, Elaine Kuhn, Mingen Liu, Andrea Anampa-Guzman, Megha Shalavadi, Colin Thomas, Melissa Kives, Ning C. Dong, Alexander Hershey, Neil Palmisiano, Alexey V. Danilov, Francisco J. Hernandez-Ilizaliturri, Stefan K. Barta, Frederick Lansigan, Kerry J. Savage, Andrew M. Evens
Journal: Blood
Blood (2021) 138 (Supplement 1): 50.
https://doi.org/10.1182/blood-2021-149728
Published: 2021
Journal Articles

a Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

Kami J. Maddocks, MD, Jonathon B. Cohen, MD, Ying Huang, MA, MS, Beth A Christian, MD, Don M Benson, MD PhD, Jeffrey Jones, MD MPH, Christopher Flowers, MD MS, Leonard T. Heffner, MD, Cynthia Jenkins, RN, Jennfer Sexton, MHA, CCRC, Alison Neal, MPH, Melissa Kives, MPH, Kristie A. Blum, MD
Journal: Blood
Blood (2016) 128 (22): 1776.
https://doi.org/10.1182/blood.V128.22.1776.1776
Published: 2016